# Hyperthyroidism: Methimazole Plus L-carnitine and Selenium

> **NCT04946123** · NA · COMPLETED · sponsor: **Lo.Li.Pharma s.r.l** · enrollment: 60 (actual)

## Conditions studied

- Hyperthyroidism

## Interventions

- **DIETARY_SUPPLEMENT:** L-carnitine+Selenium

## Key facts

- **NCT ID:** NCT04946123
- **Lead sponsor:** Lo.Li.Pharma s.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-05
- **Primary completion:** 2025-06-04
- **Final completion:** 2025-06-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04946123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04946123, "Hyperthyroidism: Methimazole Plus L-carnitine and Selenium". Retrieved via AI Analytics 2026-08-13 from https://api.ai-analytics.org/clinical/NCT04946123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*